Dr. Shelley R. Mcdonald
Overview
As a physician, I strive to create a partnership with my patients, aiming to optimize their medical conditions while respecting their personal preferences to help each older adult maintain autonomy. I grew up in Central Texas and had a close relationship with my grandmother, which taught me at an early age to appreciate how much older adults value independence.
Dr. Mcdonald is rated as an Experienced provider by MediFind in the treatment of Fabry Disease. Her top areas of expertise are Muscle Invasive Bladder Cancer and Non-Muscle Invasive Bladder Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
4220 N Roxboro St, Durham, NC 27704
Triangle Fily Practice
I love the variety and unique challenges that primary care offers. I see patients for urgent visits, management of chronic medical conditions (such as diabetes and high blood pressure), routine physicals, well-child checks, and office-based procedures. I encourage patients to actively participate in their medical care and strive to cater treatment plans to individual preferences and values. When I'm not in the office, I enjoy spending time hiking, running, gardening, playing with my dog, and spoiling my nephew. Dr. Beidler is rated as an Experienced provider by MediFind in the treatment of Fabry Disease. Her top areas of expertise are Fabry Disease, Multiple Sulfatase Deficiency, Megalencephalic Leukoencephalopathy with Subcortical Cysts, and Type 2 Diabetes (T2D).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Muscle Invasive Bladder CancerDr. Mcdonald isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Mcdonald isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.